{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:32:24Z","timestamp":1789025544781,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Research Foundation, South Africa"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12105-020-01226-z","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T20:02:25Z","timestamp":1600718545000},"page":"491-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Expression of Mucins in Salivary Gland Mucoepidermoid Carcinoma"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0549-7824","authenticated-orcid":false,"given":"Liam","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-8352","authenticated-orcid":false,"given":"Marlene B.","family":"van Heerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4660-7612","authenticated-orcid":false,"given":"Jason G.","family":"Ker-Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7873-0877","authenticated-orcid":false,"given":"Keith D.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-667X","authenticated-orcid":false,"given":"Willie F. P.","family":"van Heerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"1226_CR1","volume-title":"AFIP atlas of tumor pathology","author":"GL Ellis","year":"2008","unstructured":"Ellis GL, Auclair PL. AFIP atlas of tumor pathology. Washington, DC: American Registry of Pathology in Collaboration with the Armed Forces Institute of Pathology; 2008."},{"key":"1226_CR2","volume-title":"World Health Organization classification of tumours","author":"AK El-Naggar","year":"2017","unstructured":"El-Naggar AK, Chan JKC, Rubin-Grandis J, Takata T, Slootweg PJ, International Agency for Research on Cancer. World Health Organization classification of tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2017.","edition":"4"},{"issue":"7","key":"1226_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00000478-200107000-00001","volume":"25","author":"MS Brandwein","year":"2001","unstructured":"Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835\u201345.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1226_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/PCR.0b013e31822489f8","volume":"16","author":"CC Griffith","year":"2011","unstructured":"Griffith CC, Seethala RR. Mucoepidermoid carcinoma of minor salivary glands: potential pitfalls and prognostic challenges. Pathol Case Rev. 2011;16(4):145\u201350.","journal-title":"Pathol Case Rev"},{"issue":"4","key":"1226_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/(SICI)1097-0142(19980825)84:4<231::AID-CNCR8>3.0.CO;2-P","volume":"84","author":"J Klijanienko","year":"1998","unstructured":"Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Validire P, Vielh P. Mucoepidermoid carcinoma ex pleomorphic adenoma: nonspecific preoperative cytologic findings in six cases. Cancer. 1998;84(4):231\u20134.","journal-title":"Cancer"},{"issue":"8","key":"1226_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0278-2391(90)90349-7","volume":"48","author":"CA Waldron","year":"1990","unstructured":"Waldron CA, Koh ML. Central mucoepidermoid carcinoma of the jaws: report of four cases with analysis of the literature and discussion of the relationship to mucoepidermoid, sialodontogenic, and glandular odontogenic cysts. J Oral Maxillofac Surg. 1990;48(8):871\u20137.","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"1226_CR7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/modpathol.2009.126","volume":"22","author":"T Nakayama","year":"2009","unstructured":"Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, et al. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol. 2009;22(12):1575\u201381.","journal-title":"Mod Pathol"},{"issue":"1","key":"1226_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/PAS.0000000000000932","volume":"42","author":"JA Bishop","year":"2018","unstructured":"Bishop JA, Cowan ML, Shum CH, Westra WH. MAML2 rearrangements in variant forms of mucoepidermoid carcinoma: ancillary diagnostic testing for the ciliated and warthin-like variants. Am J Surg Pathol. 2018;42(1):130\u20136.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1226_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.oooo.2016.01.003","volume":"121","author":"PP Luk","year":"2016","unstructured":"Luk PP, Wykes J, Selinger CI, Ekmejian R, Tay J, Gao K, et al. Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(5):530\u201341.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"8","key":"1226_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/PAS.0b013e3181de3021","volume":"34","author":"RR Seethala","year":"2010","unstructured":"Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN. A reappraisal of the MECT1\/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010;34(8):1106\u201321.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1226_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/gcc.20306","volume":"45","author":"A Behboudi","year":"2006","unstructured":"Behboudi A, Enlund F, Winnes M, Andren Y, Nordkvist A, Leivo I, et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosom Cancer. 2006;45(5):470\u201381.","journal-title":"Genes Chromosom Cancer"},{"issue":"3","key":"1226_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamaoto.2015.3270","volume":"142","author":"RE Saade","year":"2016","unstructured":"Saade RE, Bell D, Garcia J, Roberts D, Weber R. Role of CRTC1\/MAML2 translocation in the prognosis and clinical outcomes of mucoepidermoid carcinoma. JAMA Otolaryngol Head Neck Surg. 2016;142(3):234\u201340.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"1226_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/01.pap.0000213058.74509.d3","volume":"13","author":"MA Luna","year":"2006","unstructured":"Luna MA. Salivary mucoepidermoid carcinoma: revisited. Adv Anat Pathol. 2006;13(6):293\u2013307.","journal-title":"Adv Anat Pathol"},{"issue":"8","key":"1226_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/PAS.0000000000000676","volume":"40","author":"RR Seethala","year":"2016","unstructured":"Seethala RR, Chiosea SI. MAML2 status in mucoepidermoid carcinoma can no longer be considered a prognostic marker. Am J Surg Pathol. 2016;40(8):1151\u20133.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1226_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/PAS.0000000000001252","volume":"43","author":"NA Cipriani","year":"2019","unstructured":"Cipriani NA, Lusardi JJ, McElherne J, Pearson AT, Olivas AD, Fitzpatrick C, et al. Mucoepidermoid carcinoma: a comparison of histologic grading systems and relationship to MAML2 rearrangement and prognosis. Am J Surg Pathol. 2019;43(7):885\u201397.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1226_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12105-009-0102-9","volume":"3","author":"RR Seethala","year":"2009","unstructured":"Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3(1):69\u201377.","journal-title":"Head Neck Pathol"},{"issue":"7","key":"1226_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C","volume":"82","author":"RK Goode","year":"1998","unstructured":"Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82(7):1217\u201324.","journal-title":"Cancer"},{"issue":"4","key":"1226_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00879270","volume":"254","author":"P Gemryd","year":"1997","unstructured":"Gemryd P, Lundquist PG, Tytor M, Hellquist HB, Nordenskjold B. Prognostic significance of DNA ploidy in mucoepidermoid carcinoma. Eur Arch Otorhinolaryngol. 1997;254(4):180\u20135.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"1226_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archotol.130.2.174","volume":"130","author":"FR Pires","year":"2004","unstructured":"Pires FR, de Almeida OP, de Araujo VC, Kowalski LP. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(2):174\u201380.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"3c","key":"1226_CR20","first-page":"2589","volume":"25","author":"WF Van Heerden","year":"2005","unstructured":"Van Heerden WF, Raubenheimer EJ, Dreyer L. The role of DNA ploidy and Ki-67 in the grading of mucoepidermoid carcinomas. Anticancer Res. 2005;25(3c):2589\u201392.","journal-title":"Anticancer Res"},{"issue":"8","key":"1226_CR21","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/cncr.23825","volume":"113","author":"MA Nance","year":"2008","unstructured":"Nance MA, Seethala RR, Wang Y, Chiosea SI, Myers EN, Johnson JT, et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer. 2008;113(8):2082\u20139.","journal-title":"Cancer"},{"key":"1226_CR22","unstructured":"Llupi M, Qoku R. Expression of mucins in normal salivary glands and mucoepidermoid carcinoma of salivary glands. 2013."},{"issue":"1","key":"1226_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1309\/9R6673QEC06D86Y4","volume":"122","author":"SK Lau","year":"2004","unstructured":"Lau SK, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol. 2004;122(1):61\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"1226_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/carcin\/bgy019","volume":"39","author":"SR Krishn","year":"2018","unstructured":"Krishn SR, Ganguly K, Kaur S, Batra SK. Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view. Carcinogenesis. 2018;39(5):633\u201351.","journal-title":"Carcinogenesis"},{"issue":"6","key":"1226_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/01.pas.0000155856.84553.c9","volume":"29","author":"L Alos","year":"2005","unstructured":"Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, et al. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol. 2005;29(6):806\u201313.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1226_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4(1):45\u201360.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1226_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/lary.21164","volume":"121","author":"N Shemirani","year":"2011","unstructured":"Shemirani N, Osipov V, Kolker A, Khampang P, Kerschner JE. Expression of mucin (MUC) genes in mucoepidermoid carcinoma. Laryngoscope. 2011;121(1):167\u201370.","journal-title":"Laryngoscope"},{"issue":"4","key":"1226_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.mpdhp.2020.01.001","volume":"26","author":"PM Speight","year":"2020","unstructured":"Speight PM, Barrett AW. Salivary gland tumours: diagnostic challenges and an update on the latest WHO classification. Diagn Histopathol. 2020;26(4):147\u201358.","journal-title":"Diagn Histopathol"},{"issue":"11","key":"1226_CR29","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A","volume":"91","author":"JJ Rahn","year":"2001","unstructured":"Rahn JJ, Dabbagh L, Pasdar M, Hugh JC. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer. 2001;91(11):1973\u201382.","journal-title":"Cancer"},{"issue":"11","key":"1226_CR30","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1158\/0008-5472.CAN-03-1460","volume":"64","author":"VB Wreesmann","year":"2004","unstructured":"Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, et al. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 2004;64(11):3780\u20139.","journal-title":"Cancer Res"},{"issue":"7","key":"1226_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/01.pas.0000159103.95360.e8","volume":"29","author":"A Handra-Luca","year":"2005","unstructured":"Handra-Luca A, Lamas G, Bertrand JC, Fouret P. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol. 2005;29(7):881\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1226_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/jop.12170","volume":"43","author":"L Siyi","year":"2014","unstructured":"Siyi L, Shengwen L, Min R, Wenjun Y, Lizheng W, Chenping Z. Increased expression of MUC-1 has close relation with patient survivor in high-grade salivary gland mucoepidermoid carcinoma. J Oral Pathol Med. 2014;43(8):579\u201384.","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"1226_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<162::AID-IJC3>3.0.CO;2-R","volume":"86","author":"MC Copin","year":"2000","unstructured":"Copin MC, Devisme L, Buisine MP, Marquette CH, Wurtz A, Aubert JP, et al. From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes. Int J Cancer. 2000;86(2):162\u20138.","journal-title":"Int J Cancer"},{"issue":"49","key":"1226_CR34","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1038\/sj.onc.1205970","volume":"21","author":"S Jepson","year":"2002","unstructured":"Jepson S, Komatsu M, Haq B, Arango ME, Huang D, Carraway CA, et al. Muc4\/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB\/Akt pathways. Oncogene. 2002;21(49):7524\u201332.","journal-title":"Oncogene"},{"issue":"6","key":"1226_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/biof.64","volume":"35","author":"S Rachagani","year":"2009","unstructured":"Rachagani S, Torres MP, Moniaux N, Batra SK. Current status of mucins in the diagnosis and therapy of cancer. BioFactors. 2009;35(6):509\u201327.","journal-title":"BioFactors"},{"issue":"3","key":"1226_CR36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3892\/ijo.2013.1760","volume":"42","author":"H Hoshi","year":"2013","unstructured":"Hoshi H, Sawada T, Uchida M, Iijima H, Kimura K, Hirakawa K, et al. MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways. Int J Oncol. 2013;42(3):887\u201393.","journal-title":"Int J Oncol"},{"issue":"1","key":"1226_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ijc.28345","volume":"134","author":"SM Kim","year":"2014","unstructured":"Kim SM, Kwon CH, Shin N, Park DY, Moon HJ, Kim GH, et al. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer. Int J Cancer. 2014;134(1):114\u201324.","journal-title":"Int J Cancer"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01226-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-020-01226-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01226-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:27:25Z","timestamp":1632184045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-020-01226-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1007\/s12105-020-01226-z","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the University of Pretoria, Faculty of Health Sciences Research Ethics Committee (Reference no.: 759\/2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}